Exchange Traded Concepts LLC Acquires Shares of 79,469 OraSure Technologies, Inc. (NASDAQ:OSUR)

Exchange Traded Concepts LLC bought a new position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 79,469 shares of the medical instruments supplier’s stock, valued at approximately $287,000. Exchange Traded Concepts LLC owned about 0.11% of OraSure Technologies at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Sei Investments Co. grew its position in OraSure Technologies by 76.9% during the 2nd quarter. Sei Investments Co. now owns 302,043 shares of the medical instruments supplier’s stock worth $1,287,000 after purchasing an additional 131,295 shares during the last quarter. Marshall Wace LLP acquired a new stake in shares of OraSure Technologies during the second quarter worth about $203,000. Squarepoint Ops LLC grew its holdings in shares of OraSure Technologies by 1,348.5% during the second quarter. Squarepoint Ops LLC now owns 249,641 shares of the medical instruments supplier’s stock worth $1,063,000 after buying an additional 232,407 shares during the last quarter. AQR Capital Management LLC increased its position in OraSure Technologies by 31.3% in the 2nd quarter. AQR Capital Management LLC now owns 810,746 shares of the medical instruments supplier’s stock valued at $3,454,000 after acquiring an additional 193,172 shares during the period. Finally, Millennium Management LLC raised its stake in OraSure Technologies by 727.5% during the 2nd quarter. Millennium Management LLC now owns 2,021,126 shares of the medical instruments supplier’s stock valued at $8,610,000 after acquiring an additional 1,776,867 shares during the last quarter. 93.50% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, StockNews.com downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday.

OraSure Technologies Stock Performance

OSUR stock opened at $4.02 on Friday. OraSure Technologies, Inc. has a one year low of $3.52 and a one year high of $8.04. The company has a fifty day moving average of $3.80 and a 200-day moving average of $4.08. The stock has a market capitalization of $299.85 million, a PE ratio of 26.80 and a beta of 0.05.

OraSure Technologies (NASDAQ:OSUR) last announced its quarterly earnings data on Wednesday, November 6th. The medical instruments supplier reported ($0.06) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. OraSure Technologies had a return on equity of 3.55% and a net margin of 5.07%. The company had revenue of $39.92 million for the quarter, compared to analyst estimates of $38.97 million. During the same quarter in the previous year, the company earned $0.27 EPS. The firm’s revenue for the quarter was down 55.2% compared to the same quarter last year. Equities analysts forecast that OraSure Technologies, Inc. will post -0.08 earnings per share for the current fiscal year.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.